Target intelligence / Profile preview

Long intergenic non-protein coding RNA 290 (LINC00290)

Target
LINC00290
Molecular classification
Long non-coding RNA (lncRNA), intergenic non-coding RNA[1][5][7]
01

Overview

Long intergenic non-protein coding RNA 290 (LINC00290) is a human long non-coding RNA gene located on chromosome 4. It is classified as a long intergenic non-protein coding RNA (lincRNA), indicating it does not encode a protein. The locus has very low protein-coding potential, with evidence suggesting it acts as a functional RNA transcript rather than as a template for protein production[1][5][9]. Currently, there is no robust documentation of its involvement in signaling, regulatory, or disease pathways, nor has it been established as a therapeutic target, receptor, enzyme, or related druggable biomolecule[1][5][7]. It may serve as a genomic marker in certain genetic association studies, but no direct functional involvement in disease has been established as of the present literature[3]. Key Points: - LINC00290 is best described as a non-coding RNA, not a protein or canonical drug target. - There is no established therapeutic relevance (i.e., not a recognized receptor, enzyme, transporter, or signaling node in drug discovery). - No validated functional role or interacting drugs are reported; it is mainly annotated in genomic and transcriptomic databases[1][5][9].

Other names
NCRNA00290RP11-810C20.1hCG2025798LINC00290-001NONHSAT099415ENSG00000248197NR_033918[1][5][7]
02

Biological functions

Other (non-coding RNA)No protein-coding or classical signaling/receptor/enzymatic/transcriptional activity documented as of current knowledge[1][5][7]
03

Disease associations

Other (no clear or direct disease association is established in the main literature)possible genomic variant marker (see GWAS reference but no clear phenotype or mechanistic role specified)[3]

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 290 (LINC00290).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 290 (LINC00290).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call